| Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair A Shabbir, D Zisa, H Lin, M Mastri, G Roloff, G Suzuki, T Lee American Journal of Physiology-Heart and Circulatory Physiology 299 (5 …, 2010 | 119 | 2010 |
| Next-Generation Sequencing Delineates Clonal Origins and Informs Therapeutic Strategies in Acute Lymphoblastic Leukemia and Histiocytic Sarcoma GW Roloff, JI Baron, VT Neppalli, S Sait, EA Griffiths JCO Precision Oncology 3, 1-8, 2019 | 109 | 2019 |
| NY-ESO-1 vaccination in combination with decitabine induces antigen-specific T-lymphocyte responses in patients with myelodysplastic syndrome EA Griffiths, P Srivastava, J Matsuzaki, Z Brumberger, ES Wang, J Kocent, ... Clinical Cancer Research 24 (5), 1019-1029, 2018 | 95 | 2018 |
| When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter GW Roloff, EA Griffiths Hematology 2014, the American Society of Hematology Education Program Book …, 2018 | 52 | 2018 |
| Technical advances in the measurement of residual disease in acute myeloid leukemia GW Roloff, C Lai, CS Hourigan, LW Dillon Journal of clinical medicine 6 (9), 87, 2017 | 43 | 2017 |
| Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia LW Dillon, S Hayati, GW Roloff, I Tunc, M Pirooznia, A Mitrofanova, ... Haematologica 104 (2), 297, 2019 | 42 | 2019 |
| Contemporary approach to acute myeloid leukemia therapy in 2022 GW Roloff, O Odenike, A Bajel, AH Wei, N Foley, GL Uy American Society of Clinical Oncology Educational Book 42, 568-583, 2022 | 40 | 2022 |
| Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies C Saygin, G Roloff, CN Hahn, R Chhetri, S Gill, H Elmariah, C Talati, ... Blood Advances 7 (4), 549-554, 2023 | 34 | 2023 |
| Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology GW Roloff, MW Drazer, LA Godley JCO Precision Oncology 5, 107-122, 2021 | 34 | 2021 |
| Tissue-of-origin-specific gene repositioning in breast and prostate cancer KJ Meaburn, O Agunloye, M Devine, M Leshner, GW Roloff, LD True, ... Histochemistry and cell biology 145, 433-446, 2016 | 29 | 2016 |
| Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies GW Roloff, LA Godley, MW Drazer Genetics in Medicine 23 (1), 211-214, 2021 | 26 | 2021 |
| Locus-specific gene repositioning in prostate cancer M Leshner, M Devine, GW Roloff, LD True, T Misteli, KJ Meaburn Molecular biology of the cell 27 (2), 236-246, 2016 | 25 | 2016 |
| Molecular measurable residual disease testing of blood during AML cytotoxic therapy for early prediction of clinical response HY Wong, AD Sung, KE Lindblad, S Sheela, GW Roloff, D Rizzieri, ... Frontiers in oncology 8, 669, 2019 | 21 | 2019 |
| Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid Leukemia K Ahmadmehrabi, AR Haque, A Aleem, EA Griffiths, GW Roloff Cancers 13 (18), 4646, 2021 | 14 | 2021 |
| Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B-Cell ALL: Outcomes and Novel Insights from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA) GW Roloff, I Aldoss, NE Kopmar, C Lin, SE Dekker, VK Gupta, ... Blood 142, 1030, 2023 | 13 | 2023 |
| Outcomes following brexucabtagene autoleucel administered as an FDA-approved therapy for adults with relapsed/refractory B-ALL. G Roloff, R Faramand, I Aldoss, NE Kopmar, M Schwartz, SE Dekker, ... Journal of Clinical Oncology 41 (16_suppl), 7001-7001, 2023 | 9 | 2023 |
| Colon cancer metastasis to the thyroid gland: report of a case with unique molecular profile GW Roloff, Z Yang, LV Wood, VK Neychev Clinical case reports 4 (6), 549, 2016 | 7 | 2016 |
| Stagnation in quality of next‐generation sequencing assays for the diagnosis of hereditary hematopoietic malignancies GW Roloff, R Shaw, TE O'Connor, F Hathaway, MW Drazer Journal of Genetic Counseling, 2023 | 6 | 2023 |
| Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies C Saygin, GW Roloff, CN Hahn, R Chhetri, S Gill, H Elmariah, C Talati, ... Blood 140 (Supplement 1), 10542-10544, 2022 | 6 | 2022 |
| Application of next-generation sequencing-based mutational profiling in acute lymphoblastic leukemia A Aleem, AR Haque, GW Roloff, EA Griffiths Current Hematologic Malignancy Reports, 1-11, 2021 | 6 | 2021 |